Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer

Published:2015-05-30 Issue:2 Volume:76 Page:235-242
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Farhat Fadi S.,Ghosn Marwan G.,Kattan Joseph G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2785-9.pdf

Reference36 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

2. Cortes-Funes H (2002) New treatment approaches for lung cancer and impact on survival. Semin Oncol 29:26–29

3. Pallis AG, Georgoulias V (2012) Is there a standard regimen for first-line treatment of advanced/metastatic non-small-cell lung cancer? What has meta-analyses contributed to today’s standard of care. Lung Cancer 75:269–274

4. Shamseddine A, Saleh A, Charafeddine M et al (2014) Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Metr 12:4

5. Manegold C (2001) Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer 34(Suppl 2):S165–S170

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03);Therapeutic Advances in Medical Oncology;2021-01

2. Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2020-05-29

3. Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial;Lung Cancer;2019-06

4. Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection;Biomedicine & Pharmacotherapy;2017-06

5. Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer;Expert Opinion on Pharmacotherapy;2017-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3